Cytomegalovirus: Clinical virological correlations in renal transplant recipients - PubMed (original) (raw)
Cytomegalovirus: Clinical virological correlations in renal transplant recipients
R L Simmons et al. Ann Surg. 1974 Oct.
Abstract
One-hundred thirty-two renal transplant recipients were systematically screened for viral infections and the findings correlated with the clinical course. One-hundred ten patients showed evidence of infection with herpesviruses and 89 patients showed laboratory evidence of infection with cytomegalovirus (CMV) uncomplicated by bacterial infections or technical complications. Patients without viral infections were usually asymptomatic. After recovery and development of anti-viral antibodies, most patients were asymptomatic despite the persistence of viral excretion in the urine. In contrast, the onset of viral infections were almost always accompanied by a significant clinical illness characterized by fever, leukopenia, and renal malfunction. Of 89 patients with cytomegalovirus infections, 83 survived at least three months. In these patients, the fever appeared to be self-limited and resolution of the fever was accompanied by increases in anti-CMV antibody. Renal biopsies demonstrated typical rejection reactions in all the biopsied patients and renal malfunction usually responded to anti-rejection treatment. Six of the 89 patients with CMV infections died within a month of viral isolation. These patients could be distinguished from those who recovered by a decreased or absent antibody response to the virus, suppressed lymphocyte responses to mitogen in autochthonous blood, and absent histologic evidence of rejection in the renal allografts. Thus, two paradoxical responses to CMV infections are seen in transplant patients: In the relatively immunocompetent patient, the infection is associated with renal allograft rejection, a prompt antibody response to the virus, and recovery. The severely immunosuppressed patient cannot make an antibody response, does not exhibit allograft rejection as a cause of renal malfunction, he may be further immunosuppressed by the viral infection, and is susceptible to sequential opportunistic infections leading to death.
Similar articles
- Association of renal allograft rejection with virus infections.
Lopez C, Simmons RL, Mauer SM, Najarian JS, Good RA, Gentry S. Lopez C, et al. Am J Med. 1974 Mar;56(3):280-9. doi: 10.1016/0002-9343(74)90609-3. Am J Med. 1974. PMID: 4360465 No abstract available. - Virus infections may trigger rejection in immunosuppressed renal transplant recipients.
Lopez C, Simmons RL, Mauer SM, Park B, Najarian JS, Good RA. Lopez C, et al. Proc Clin Dial Transplant Forum. 1972;2:107-11. Proc Clin Dial Transplant Forum. 1972. PMID: 4377589 No abstract available. - Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation.
Simmons RL, Matas AJ, Rattazzi LC, Balfour HH Jr, Howard JR, Najarian JS. Simmons RL, et al. Surgery. 1977 Nov;82(5):537-46. Surgery. 1977. PMID: 199956 - Basiliximab: a review of its use as induction therapy in renal transplantation.
Chapman TM, Keating GM. Chapman TM, et al. Drugs. 2003;63(24):2803-35. doi: 10.2165/00003495-200363240-00009. Drugs. 2003. PMID: 14664658 Review. - Cytomegalovirus (CMV) in the compromised host(s).
Betts RF, Hanshaw JB. Betts RF, et al. Annu Rev Med. 1977;28:103-10. doi: 10.1146/annurev.me.28.020177.000535. Annu Rev Med. 1977. PMID: 193429 Review.
Cited by
- Enhancement of Cytomegalovirus-Specific Cytokine Production after Modulation of the Costimulation in Kidney Transplant Patients.
Dornieden T, Wilde B, Korth J, Werner K, Horn PA, Witzke O, Lindemann M. Dornieden T, et al. J Immunol Res. 2019 Feb 25;2019:3926175. doi: 10.1155/2019/3926175. eCollection 2019. J Immunol Res. 2019. PMID: 30931336 Free PMC article. - Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application.
Kobayashi T, Sato JI, Ikuta K, Kanno R, Nishiyama K, Koshizuka T, Ishioka K, Suzutani T. Kobayashi T, et al. Fukushima J Med Sci. 2017 Aug 9;63(2):64-74. doi: 10.5387/fms.2017-01. Epub 2017 Jun 22. Fukushima J Med Sci. 2017. PMID: 28638004 Free PMC article. - Cytomegalovirus in the Pediatric Transplant Recipient: Where Are We Now?
Michaels MG, Humar A. Michaels MG, et al. Transplantation. 2017 Apr;101(4):686-687. doi: 10.1097/TP.0000000000001627. Transplantation. 2017. PMID: 28045876 Free PMC article. No abstract available. - OKT3 and viral disease in pediatric liver transplant recipients.
Bowman JS, Green M, Scantlebury VP, Todo S, Tzakis A, Iwatsuki S, Douglas L, Starzl TE. Bowman JS, et al. Clin Transplant. 1991 Aug;5(4):294-300. Clin Transplant. 1991. PMID: 21170278 Free PMC article. - Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.
Welsh RM, Markees TG, Woda BA, Daniels KA, Brehm MA, Mordes JP, Greiner DL, Rossini AA. Welsh RM, et al. J Virol. 2000 Mar;74(5):2210-8. doi: 10.1128/jvi.74.5.2210-2218.2000. J Virol. 2000. PMID: 10666251 Free PMC article.
References
- Br Med J. 1972 Dec 2;4(5839):520-2 - PubMed
- JAMA. 1964 Sep 14;189:808-12 - PubMed
- Transplant Proc. 1971 Mar;3(1):343-6 - PubMed
- Arch Surg. 1972 Oct;105(4):564-70 - PubMed
- Am J Dis Child. 1970 Sep;120(3):197-202 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources